Literature DB >> 15485324

Treatment of laryngeal cancer: the permanent challenge.

Jean Louis Lefebvre1, Bernard Coche-Dequéant, Marian Degardin, Ahmed Kara, Yann Mallet, Jean Ton Van.   

Abstract

There are many options to treat larynx cancers. Throughout the 20th century, surgical research has provided many partial surgery techniques (either open surgery or endoscopic CO2 surgery). In parallel, the modification of radiotherapy schedules has notably improved the local control with definitive irradiation. The appearance of active chemotherapy regimens has also modified the concept of treatment for advanced disease, allowing a decrease in the total indications of laryngectomy, although this remains the treatment of choice in some cases. The selection of the most appropriate treatment is based on a multidisciplinary approach. Early diseases may be treated by open surgery, endoscopic laser CO2 surgery or irradiation. Some advanced diseases may be treated by partial surgery, but the majority are theoretically candidates for radical surgery when resectable. In many instances, but not in all, chemotherapy-based larynx-preserving protocols may avoid performing such mutilating surgery. When inoperable, larynx cancers are better treated by combined chemotherapy and irradiation when the performance status of the patient is compatible with such an intensive regimen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485324     DOI: 10.1586/14737140.4.5.913

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.

Authors:  Liang Han; Bin Jiang; Hao Wu; Shu Zhang; Xueguan Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis.

Authors:  Zhisen Shen; Wenjuan Hao; Chongchang Zhou; Hongxia Deng; Dong Ye; Qun Li; Lexi Lin; Bing Cao; Junming Guo
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

3.  Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.

Authors:  Yewen Shi; Qingqing Zhang; Meng Xie; Yani Feng; Sijing Ma; Chunxi Yi; Zihan Wang; Yanju Li; Xiaohong Liu; Haiqin Liu; Hui Yang; Yan Yan; Yitong Zhang; Xiaoyong Ren; Huanan Luo
Journal:  Oncol Rep       Date:  2020-10-23       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.